Published in Clin Neuropharmacol on August 01, 2002
Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study. J Neurol (2007) 1.65
'The clocks that time us'--circadian rhythms in neurodegenerative disorders. Nat Rev Neurol (2014) 1.20
Hallucinations in Parkinson disease. Nat Rev Neurol (2009) 1.13
Circadian rhythm connections to oxidative stress: implications for human health. Antioxid Redox Signal (2013) 1.00
Repeat variation in the human PER2 gene as a new genetic marker associated with cocaine addiction and brain dopamine D2 receptor availability. Transl Psychiatry (2012) 0.96
Therapeutic potential of melatonin and its analogs in Parkinson's disease: focus on sleep and neuroprotection. Ther Adv Neurol Disord (2011) 0.90
Short- and long-term effects of tactile massage on salivary cortisol concentrations in Parkinson's disease: a randomised controlled pilot study. BMC Complement Altern Med (2013) 0.87
Diurnal salivary cortisol concentrations in Parkinson's disease: increased total secretion and morning cortisol concentrations. Int J Gen Med (2011) 0.81
Diurnal influences on electrophysiological oscillations and coupling in the dorsal striatum and cerebellar cortex of the anesthetized rat. Front Syst Neurosci (2014) 0.79
Bright light therapy in Parkinson's disease: an overview of the background and evidence. Parkinsons Dis (2012) 0.79
Associations of PER3 and RORA Circadian Gene Polymorphisms and Depressive Symptoms in Older Adults. Am J Geriatr Psychiatry (2015) 0.78
Subtle cardiovascular dysfunction in the unilateral 6-hydroxydopamine-lesioned rat. Parkinsons Dis (2010) 0.77
Autonomic nervous system and risk factors for vascular disease. Effects of autonomic unbalance in schizophrenia and Parkinson's disease. Neurol Sci (2008) 0.77
Melatoninergic System in Parkinson's Disease: From Neuroprotection to the Management of Motor and Nonmotor Symptoms. Oxid Med Cell Longev (2016) 0.75
Pharmacodynamics of unfractionated heparin during and after a hemodialysis session. Am J Kidney Dis (2008) 1.64
Vancomycin: a review of population pharmacokinetic analyses. Clin Pharmacokinet (2012) 1.53
Unexpected overestimation of methotrexate plasma concentrations: analysis of a single center pediatric population. Ther Drug Monit (2014) 1.38
Population pharmacokinetics of atazanavir in human immunodeficiency virus-infected patients. Ther Drug Monit (2008) 1.09
Impact of multiaccess infusion devices on in vitro drug delivery during multi-infusion therapy. Anesth Analg (2009) 1.00
Minimal effect of MDR1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of indinavir in HIV-infected patients. Br J Clin Pharmacol (2007) 0.98
Population pharmacokinetics of ceftriaxone in critically ill septic patients: a reappraisal. Br J Clin Pharmacol (2011) 0.95
Pharmacokinetics of the low molecular weight heparin enoxaparin during 48 h after bolus administration as an anticoagulant in haemodialysis. Nephrol Dial Transplant (2003) 0.95
Population pharmacokinetic analysis during the first 2 years of life: an overview. Clin Pharmacokinet (2012) 0.93
Off-Label Prescribing of Antipsychotics in Adults, Children and Elderly Individuals: A Systematic Review of Recent Prescription Trends. Curr Pharm Des (2015) 0.92
Self-intoxication with baclofen in alcohol-dependent patients with co-existing psychiatric illness: an emergency department case series. Alcohol Alcohol (2013) 0.87
Intravenous morphine titration in immediate postoperative pain management: population kinetic-pharmacodynamic and logistic regression analysis. Pain (2009) 0.86
Infusion set characteristics such as antireflux valve and dead-space volume affect drug delivery: an experimental study designed to enhance infusion sets. Anesth Analg (2010) 0.85
P-glycoprotein and cytochrome P450 3A4 involvement in risperidone transport using an in vitro Caco-2/TC7 model and an in vivo model. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.85
Biological rhythms: a neglected factor of variability in pharmacokinetic studies. J Pharm Sci (2008) 0.84
Impact of plasma and intracellular exposure and CYP3A4, CYP3A5, and ABCB1 genetic polymorphisms on vincristine-induced neurotoxicity. Cancer Chemother Pharmacol (2011) 0.84
Which improvements could prevent the departure of the left-without-being-seen patients? Emerg Med J (2010) 0.83
Population pharmacokinetics and pharmacogenetics of vincristine in paediatric patients treated for solid tumour diseases. Cancer Chemother Pharmacol (2010) 0.81
Performance of target-controlled sufentanil infusion in obese patients. Anesthesiology (2003) 0.80
Population Pharmacokinetics of High-Dose Oxazepam in Alcohol-Dependent Patients: Is There a Risk of Accumulation? Ther Drug Monit (2016) 0.80
The impact on drug mass flow rate of interrupting and resuming carrier fluid flow: an in vitro study on a very low dead-space volume infusion set. Anesth Analg (2011) 0.79
Effects of L-Dopa on circadian rhythms of 6-OHDA striatal lesioned rats: a radiotelemetric study. Chronobiol Int (2010) 0.79
Cluster analysis: an alternative method for covariate selection in population pharmacokinetic modeling. J Pharmacokinet Pharmacodyn (2005) 0.78
Pediatric Patients With Solid or Hematological Tumor Disease: Vancomycin Population Pharmacokinetics and Dosage Optimization. Ther Drug Monit (2016) 0.78
Cyclosporine monitoring in renal transplant recipients with induction therapy: C2 levels in patients monitored on C0. Fundam Clin Pharmacol (2006) 0.77
Effects of a seven-day continuous infusion of ropivacaine on circadian rhythms in the rat. Chronobiol Int (2006) 0.77
Poly-cyclodextrin functionalized porous bioceramics for local chemotherapy and anticancer bone reconstruction. J Biomed Mater Res B Appl Biomater (2013) 0.77
Chronopharmacokinetics of imipenem in the rat. Chronobiol Int (2007) 0.77
Effects of ursodeoxycholic acid on P-glycoprotein and cytochrome P450 3A4-dependent pharmacokinetics in humans. Clin Pharmacol Ther (2006) 0.76
Moxifloxacin penetration in bronchial secretions of mechanically ventilated patients with pneumonia. Antimicrob Agents Chemother (2004) 0.76
Intravenous abuse of methylphenidate. J Clin Psychopharmacol (2013) 0.76
Aripiprazole-induced pathological gambling: a report of 3 cases. Curr Drug Saf (2011) 0.76
Time-of-day dependent pharmacodynamic and pharmacokinetic profiles of caffeine in rats. Naunyn Schmiedebergs Arch Pharmacol (2002) 0.75
Use of extended-release methylphenidate (concerta) in treatment of cocaine dependence in a patient presenting with attention deficit hyperactivity disorder. J Neuropsychiatry Clin Neurosci (2014) 0.75
Pharmacokinetics and absolute bioavailability of phenobarbital in neonates and young infants, a population pharmacokinetic modelling approach. Fundam Clin Pharmacol (2013) 0.75
High variability in the exposure of baclofen in alcohol-dependent patients. Alcohol Clin Exp Res (2013) 0.75
[Manufacturing waste of hemodialyzers decreases oxidative phosphorylation of mitochondria isolated from rats]. Nephrol Ther (2010) 0.75
Interaction of thiopental with esomeprazole in critically ill patients. Eur J Clin Pharmacol (2013) 0.75
Mussel inspired coating of a biocompatible cyclodextrin based polymer onto CoCr vascular stents. ACS Appl Mater Interfaces (2014) 0.75
Effects of hyperthermia on pharmacokinetics of ertapenem in rats. Fundam Clin Pharmacol (2008) 0.75
Vancomycin syringe study shows significant reduction in dosing variability after introducing a revised protocol. Acta Paediatr (2013) 0.75
Independent-model diagnostics for a priori identification and interpretation of outliers from a full pharmacokinetic database: correspondence analysis, Mahalanobis distance and Andrews curves. J Pharmacokinet Pharmacodyn (2008) 0.75
Population pharmacokinetics of ertapenem in juvenile and old rats. Fundam Clin Pharmacol (2013) 0.75
[Pathological gambling and addiction to cannabis: common psychosocial profile?]. Soins Psychiatr (2014) 0.75
Baclofen and risperidone association increases dramatically triglycerides level. Alcohol Alcohol (2013) 0.75
Envenomation by caterpillars of the genus Megalopyge in French Guiana with an atypical clinical presentation, based on three observations. Clin Toxicol (Phila) (2015) 0.75
Review in pharmacokinetic models on corticosteroids. Mini Rev Med Chem (2006) 0.75
Are we ready to treat hepatitis C virus in individuals with opioid use disorder: assessment of readiness in European countries on the basis of an expert-generated model. Eur J Gastroenterol Hepatol (2017) 0.75
Child poisonings with methadone in France: A 6-year prospective national survey since the availability of capsules in 2008. Clin Toxicol (Phila) (2015) 0.75
Cocaine and repolarization disorder: myocardial ischemia? J Clin Psychopharmacol (2014) 0.75
Population pharmacokinetics of methadone hydrochloride after a single intramuscular administration in adult Japanese sika deer (Cervus nippon nippon). Vet Anaesth Analg (2014) 0.75